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 2 
Abstract 13 
The oviduct provides the natural micro-environment for gamete interaction, 14 
fertilization and early embryo development in mammals, such as the cow. In 15 
conventional culture systems, bovine oviduct epithelial cells (BOEC) undergo a rapid 16 
loss of essential differentiated cell properties; we aimed to develop a more 17 
physiological in vitro oviduct culture system capable of supporting fertilization. U-18 
shaped chambers were produced using stereo-lithography and mounted with 19 
polycarbonate membranes, which were used as culture inserts for primary BOECs. 20 
Cells were grown to confluence and cultured at an air-liquid interface for 4 to 6 weeks 21 
and subsequently either fixed for immune staining, incubated with sperm cells for live-22 
cell imaging, or used in an oocyte penetration study. Confluent BOEC cultures 23 
maintained polarization and differentiation status for at least 6 weeks. When sperm 24 
and oocytes were introduced into the system, the BOECs supported oocyte 25 
penetration in the absence of artificial sperm capacitation factors while also 26 
preventing polyspermy and parthenogenic activation, both of which occur in classical 27 
in vitro fertilization systems. Moreover, this “oviduct-on-a-chip” allowed live imaging 28 
of sperm-oviduct epithelium binding and release. Taken together, we describe for the 29 
first time the use of 3D-printing as a step further on bio-mimicking the oviduct, with 30 
polarized and differentiated BOECs in a tubular shape that can be perfused or 31 
manipulated, which is suitable for live imaging and supports in vitro fertilization.  32 
Key words: oviduct model, 3D printing, fertilization, fallopian tube  33 
 34 
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 3 
Introduction 35 
In mammals, the oviducts are paired organs that connect the uterus to the respective 36 
ovaries. The oviduct also forms the specific niche in which mammalian fertilization 37 
takes place. Its lumen provides the physiological microenvironment required for 38 
gamete interaction and early embryo development 
1–5
. Sperm enter the oviduct from 39 
the isthmic end, which is connected to the uterus by the utero-tubal junction. Close 40 
contact of sperm with the epithelium of the oviductal isthmus has been proven to be 41 
important for extending sperm survival, in a so-called ‘sperm reservoir’. It also serves 42 
to trigger subsequent activation (i.e. capacitation) around the time of ovulation. This 43 
allows sperm to detach from the isthmus and to ascend into the ampulla where 44 
fertilization will take place 
5–9
. The ampulla of the oviduct is connected to the funnel-45 
shaped infundibulum, which catches the freshly ovulated cumulus oocyte complex 46 
(COC) and directs it further into the ampulla. Final modifications of the COC takes 47 
place in the ampulla which will ensure that the oocyte is ready to become fertilized by 48 
a sperm cell 
10,11
. After fertilization, the first embryonic divisions and further 49 
development take place in the oviduct and, once the morula stage is achieved, the 50 
bovine embryo will leave the isthmic part of the oviduct to enter the uterus. 51 
Conditions for supporting fertilization and early embryo development in vitro have 52 
been developed for a wide range of species. However, despite advances in 53 
reproductive biotechnology and embryo culture media, it is clear that in vitro 54 
produced embryos differ markedly from those that develop in vivo 
12–15
. Despite 55 
common belief that the oviduct is more than a simple tube allowing the transport of 56 
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 4 
gametes and early stage embryos, the findings that in vitro embryos are of reduced 57 
developmental competence convincingly demonstrates the importance of the oviduct 58 
environment for optimal embryo development. Both the gametes and the early 59 
embryo are in close contact with the epithelial lining the oviduct. This epithelium is 60 
composed of a mixture of ciliated and non-ciliated, i.e. secretory, cells. The oviduct 61 
tubular morphology  with its intricately folded morphology
16
  influences the flux of 62 
fluids. Fluid movements are created with muscular contractions and ciliary beating 63 
which both actively support the transport of the sperm and oocyte to the ampulla, 64 
where fertilization takes place. In this respect, the critical contribution of the oviduct 65 
to the complex regulated processes of fertilization of the oocyte and optimal early 66 
embryo development remains to be elucidated in detail 
17
.  67 
One of the reasons why oviduct physiology and function has poorly been studied, due 68 
to the location of the organ being deep within the abdominal cavity. This makes it 69 
difficult to perform in vivo observational studies in mammals. Consequently, various in 70 
vitro models have been designed to study the role of oviduct epithelial cells in gamete 71 
interaction and fertilization. The most commonly used models are based on monolayer 72 
cultures of oviduct epithelial cells
7,8,18,19
, or on explant cultures of oviduct tissue that 73 
forms cellular vesicles with ciliary beating activity 
20–22
. Standard in vitro  oviduct 74 
monolayer cultures (OMs, 2D culture) are typically hampered by a rapid 75 
transformation of the differentiated, cuboidal - columnar oviduct epithelial cells (OECs) 76 
into flattened cells with a complete loss of cilia and with a reduced secretory ability 77 
18,23–25
. Recently, the use of porous membrane inserts to allow oviduct epithelial cells 78 
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 5 
to be cultured at an air-liquid interface, has been shown to allow the formation of 79 
epithelial monolayers that preserve their epithelial secretory and ciliary beating 80 
activity 
8,23,26–28
. Although, this has been a break-through in terms of cell culture, 81 
commercial insert systems do have a number of limitations for some experimental 82 
purposes. For example, it is not possible to perform live cell imaging within most 83 
inserts, and perfusion is difficult because the inserts are flat circular discs rather than 84 
mimicking the tubular structure of the oviduct.   85 
Ideally, an in vitro model of the oviduct would be compartmentalized with a 86 
basolateral perfusion compartment mimicking the blood circulation, and an 87 
independently apical perfusion compartment mimicking the luminal fluid movements 88 
of the oviduct. Such a system would allow mimicking the endocrine changes that do 89 
occur during a natural estrous cycle at the basal side and facilitate the apical addition 90 
and removal of gametes, embryos, and medium or cell secretions. Indeed, it was 91 
recently demonstrated that specific tissue morphology and functions can be preserved 92 
better in customized three-dimensional (3D) culture systems than in conventional 2D 93 
systems 
24,29–33
.  94 
Three-dimensional (3D) printing technology can generate prototypes rapidly, allowing 95 
researchers to design and print devices within a short period of time 
34
. Combined with 96 
microfluidic technology, 3D printing has led to the creation of “organs-on-a-chip” to 97 
study human and animal physiology in an organ-specific context and, thereby, create 98 
models for researching specific aspects of health, disease and toxicology 
31
. 99 
The advances of 3D printing and cell insert culture systems andthe lack of a 100 
Page 5 of 36 Lab on a Chip
La
b
on
a
C
hi
p
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
07
 F
eb
ru
ar
y 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ite
it 
U
tre
ch
t o
n 
08
/0
2/
20
17
 0
9:
35
:3
0.
 
View Article Online
DOI: 10.1039/C6LC01566B
 
 
 6 
physiological in vitro model to study oviduct function, led us to design and print a 101 
tube-like chamber in which BOECs can be cultured at an air-liquid interface that 102 
supports further epithelial polarization and differentiation during long-term culture 103 
period. We tested the designed chamber for its suitability for live imaging the 104 
interaction between sperm and oviduct cells. Furthermore, the functionality of the 105 
epithelial cells cultured in a 3D chamber for supporting fertilization is demonstrated in 106 
an oocyte penetration approach. Using this oviduct-on-a-chip design, we aim to better 107 
understand the interactive role of the oviduct environment supporting gamete 108 
interaction, early embryonic development, and ultimately to be able to produce in 109 
vitro embryos more similar to in vivo embryos than is currently possible. 110 
 111 
Materials and Methods 112 
Chemicals 113 
Unless stated otherwise, all chemicals used were obtained from Sigma Chemical Co. 114 
(St. Louis, MO) and were of the highest purity available. 115 
 116 
Three-dimensional chamber design and printing 117 
The prototype design of the oviduct–on-a-chip was created using Tinkercad (Autodesk 118 
Inc., San Francisco, CA, USA). The design included flat upper and lower surfaces to 119 
allow attachment to a glass slide for future perfusion and imaging. A curved inner 120 
chamber was created to better mimic the tubular surface of the oviduct, while 121 
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 7 
remaining shallow enough not to interfere with imaging. Inlets and outlets in both the 122 
apical and basolateral compartments were included, with the size and shape of the 123 
inlets designed to permit easy attachment of tubing and to allow adequate fluid flow. 124 
An outer cuboid chamber shape was used to facilitate later up-scaling by printing 125 
multiple conjoined parallel chambers. The design was exported from Tinkercad as an 126 
STL file, and then imported into Mimics software (Materialise NV, Leuven, Belgium) to 127 
verify and repair any mesh errors and generate printing support structures. The 128 
screenshot of the prototype including its inlets and outlets is shown in Figure 1. 129 
Three-dimensional printing of the device was performed using a photo-cured resin, 130 
PIC100 (Envisiontec GmbH, Gladbeck, Germany), via a Perfactory 3 Mini 3D printer 131 
(Envisiontec GmbH, Gladbeck, Germany) at a resolution of 50 µm, which exploits the 132 
photo-polymerization technique for 3D printing. 133 
 134 
Post-curing, mounting a porous membrane and sterilization of the 3D chamber 135 
To avoid the leakage of compounds from the printed material that might interfere with 136 
cell viability, removal of excess resin was performed by a 15 minute immersion in 137 
ethanol. After complete air drying, the chambers were immersed 3 times for 2 hours 138 
each in isopropanol solution. After repeated air drying, the chambers were light-cured 139 
using 4000 flashes in an Otoflash G171 (Envisiontec GmbH, Gladbeck, Germany). 140 
The polycarbonate membrane (0.4 µm pores; SABEU GmbH & Co. KG, Germany) was 141 
attached to the chamber using the silicone elastomer Kwik-Sil (World Precision 142 
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 8 
Instruments Inc., Florida, USA) and cured for 5 minutes at room temperature. Before 143 
incubation with cells, the chambers were sterilized by immersion for 1 hour in 70% 144 
ethanol, washed three-times for 30 minutes each in phosphate-buffered saline 145 
solution (PBS; 163.9 mM Na
+
, 140.3 mM CL
-
, 8.7 mM HPO4
3-
, 1.8 mM H2PO4
-
, pH 7.4; 146 
Braun, Melsungen, Germany) and washed for 1 hour in HEPES buffered Medium 199 147 
(Gibco BRL, Paisley, U.K.) supplemented with 100 U/mL penicillin and 100 µg/mL 148 
streptomycin (Gibco BRL, Paisley, U.K.).  149 
  150 
Isolation of oviduct cells and long term oviduct cell culture 151 
Cow oviducts were collected from a local abattoir immediately after slaughter and 152 
transported to the laboratory on ice, within two hours. The oviducts were dissected 153 
free of surrounding tissue and washed three times in cold PBS supplemented with 100 154 
U/mL of penicillin and 100 µg/mL of streptomycin. BOECs were isolated by squeezing 155 
the total oviduct contents out of the ampullary end of the oviducts, and collected in 156 
HEPES buffered Medium 199 supplemented with 100 U/mL penicillin and 100 µg/mL 157 
streptomycin. The cells were washed twice by centrifuging for 500 x g for 10 minutes 158 
at 25
o
C in HEPES buffered Medium 199 supplemented with 100 U/mL of penicillin and 159 
100 µg/mL of streptomycin. The cells were then cultured for 24 hours in HEPES 160 
buffered Medium 199 supplemented with 100 U/mL penicillin, 100 µg/mL 161 
streptomycin and 10% fetal calf serum (FCS; Bovogen Biologicals, Melbourne, 162 
Australia). During these 24 hours, the cells arranged themselves into floating vesicles 163 
with outward facing actively beating cilia; these vesicles were collected, centrifuged at 164 
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 9 
500 x g for 10 minutes at 25 
o
C, resuspended in DMEM/Ham’s F12 medium (DMEM/F-165 
12 Glutamax I, Gibco BRL, Paisley, U.K.) supplemented with 1.4 mM hydrocortisone, 5 166 
mg/mL insulin, 10 mg/mL transferrin, 2.7 mM epinephrine, 9.7 nM tri-iodothyronine, 167 
0.5 ng/mL epidermal growth factor, 50 nM trans-retinoic acid, 2 % bovine pituitary 168 
extract (containing 14 mg/mL protein), 1.5 mg/mL BSA, 100 mg/mL gentamycin, and 169 
2.5 mg/mL amphotericin B (3D culture medium, adapted from 
24
), and pipetted up and 170 
down several times to mechanically separate the cells. Next, cells were seeded either 171 
into: (i) the oviduct-on-a-chip (3D culture; 0.6 x 10
6
 cells/cm
2
) or (ii) into 24 well 172 
culture dishes with glass coverslips in the bottom of the wells (2D culture; 0.3 x 10
6
 173 
cells/cm
2
). Cells in both systems were cultured in 3D culture medium in a humidified 174 
atmosphere of 5 % CO2-in-air at 38.5 
o
C until they reached confluence (5-7 days). Once 175 
the cells had reached confluence, an air-liquid interface was established in the 3D 176 
culture by removing the medium in the apical compartment. Cells in the 3D chambers 177 
were cultured at an air-liquid interface for up to 42 days in a humidified atmosphere of 178 
5 % CO2-in-air at 38.5 
o
C. The culture medium was completely refreshed twice a week 179 
in both systems. 180 
 181 
Oocyte collection and in vitro maturation 182 
Oocyte collection and maturation was performed as described somewhere else
35
. 183 
Briefly, bovine ovaries were collected from a local abattoir and transported to the 184 
laboratory within 2 hours after dissection. The ovaries were washed in physiological 185 
saline (0.9 % w/v  NaCl) and held in physiological saline containing 100 U/mL penicillin 186 
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 10
and 100 µg/mL streptomycin at a temperature of 30
o
C.  The fluid and cumulus oocyte 187 
complexes (COCs) were aspirated from follicles with a diameter ranging from 2 to 8 188 
mm and were collected into a 50ml conical tube using a 19-gauge needle and a 189 
vacuum pump. COCs with a minimum of three layers of intact cumulus cells were 190 
selected and first washed in HEPES-buffered M199 (Gibco BRL, Paisley, U.K.)  before 191 
being washed and cultured in maturation medium (M199 supplemented with 0.02 192 
IU/mL follicle-stimulating hormone [Sioux Biochemical Inc., Sioux Center, IA]), 0.02 193 
IU/mL luteinizing hormone (Sioux Biochemical Inc.), 7.71 µg/mL cysteamine, 10 ng/mL 194 
epidermal growth factor in 0.1 % w/v fatty acid-free bovine serum albumin (BSA) and 195 
100 U/mL penicillin and 100 µg/mL streptomycin. Selected COCs were cultured in four-196 
well culture plates (Nunc A/S, Roskilde, Denmark) containing maturation medium. The 197 
oocytes were matured in groups of 50 COCs in 500 µl maturation medium and 198 
incubated in a humidified atmosphere of 5 % CO2-in-air for 24 hours at 38.5 
o
C. 199 
 200 
Sperm washing and staining with mitotracker  201 
Frozen sperm, from 3 different bulls, were thawed at 37 
o
C for 30 seconds and washed 202 
by centrifugation at 100 x g for 10 minutes through a BoviPure discontinuous gradient, 203 
following manufacture instructions (Nidacon International AB, Gothenburg, Sweden) 204 
at room temperature. The supernatant was removed, the pellet resuspended in 3 mL 205 
of BoviPure wash solution, and centrifuged again at 100 x g for 5 minutes. 206 
Spermatozoa from the 3 pellets were pooled and then incubated for 30 minutes with 207 
200 nM mitotracker green FM® or mitotracker red FM®(MTG and MTR respectively; 208 
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 11
Molecular Probes Inc., Eugene, USA) in fertilization medium (modified Tyrode’s 209 
medium supplemented with 25 mM sodium bicarbonate, 22 mM lactate, 1 mM 210 
pyruvate, 6 mg/mL fatty acid–free BSA) containing 100 U/mL penicillin and 100 µg/mL 211 
streptomycin instead of gentamycin and without glucose or activation factors (heparin, 212 
d-penicillamine, hypotaurine and epinephrine). The mitotracker stained spermatozoa 213 
were then washed three times in fertilization medium without activation factors by 214 
centrifuging at 100 x g for 5 minutes and used for in vitro fertilization. 215 
 216 
In vitro fertilization 217 
MTG stained sperm were added to the fertilization medium at a final concentration of 218 
1 x 10
6
 sperm cells/mL in the presence (control IVF, 500 µL volume) or absence (3D 219 
culture, 2D culture and no activation factors control IVF; 80, 500 and 500 µL volume, 220 
respectively) of 10 µg/ml heparin, 20 µM d-penicillamine, 10 µM hypotaurine, and 1 221 
µM epinephrine (activation factors). For the 3D culture IVF, the sperm suspension (80 222 
µL) was manually perfused to the apical compartment and-after 2 hours- unattached 223 
sperm were perfused out of the system by flushing 240 µL of PBS over the apical side 224 
of the BOEC and immediately thereafter, a total of 25 COCs were perfused to the 225 
apical compartment in 80 µL of fertilization medium without activation factors of each 226 
of the 3D culture chambers (n=8 chambers; 25 COCs per chamber). In 2D cultures 50 227 
COCs were added in 500 µL of fertilization medium without activating factors. A 228 
standard IVF protocol
35
, with or without activation factors, was performed as a control 229 
on 300 COCs. After 24 h of co-incubation under a humidified atmosphere of 5% CO2-in-230 
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 12
air at 38.5
o
C, cumulus cells were removed by pipetting and the presumptive zygotes 231 
were fixed and stained with the membrane permeable DNA stain Hoechst 33342 (5 232 
µg/mL in PBS) to distinguish parthenotes and poly-spermic from mono-spermic 233 
fertilized oocytes. All experiments were performed in 4 replicates, using 2 different 234 
animals per replicate for the 2D and 3D cultures groups.  235 
The sperm cells perfused out of the 3D culture chambers were centrifuged at 100 x g 236 
for 5 minutes, resuspended in 50 µL of fertilization medium, and the number of 237 
recovered sperm cells were calculated in order to determine the number of 238 
spermatozoa that remained bound to the epithelial cells. A routine IVF with the same 239 
number of sperm cells as the ones that remained attached to the epithelial cells in the 240 
3D culture (69 x 10
3 
sperm cells/well) and a routine IVF with same proportion of sperm 241 
cells that remained attached to the 3D culture were performed (0.431 x 10
6
 sperm 242 
cells/well, 86.25 % of sperm cells used for control IVF). After 24 hours of co-incubation 243 
under a humidified atmosphere of 5 % CO2-in-air at 38.5 
o
C, presumptive zygotes were 244 
fixed and stained as described above. 245 
 246 
Ciliation of cells and cell morphology 247 
At weeks 3, 4, 5 and 6 of air-liquid interface culture, two oviduct-on-a-chip chambers 248 
and 1 coverslip from the 2D culture was sacrificed per animal (n = 4) for assessment of 249 
cilia formation on epithelial cells. The membranes were dismounted from the chamber 250 
for immune fluorescent staining. The membranes or cover slips were washed in PBS, 251 
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 13
fixed in 4 % paraformaldehyde dissolved in PBS, and permeabilized for 30 minutes 252 
using 0.5 % Triton-X100 in PBS. Non-specific binding was blocked by incubation for 1 253 
hour in PBS containing 5 % normal goat serum, at room temperature. The cells were 254 
then incubated overnight at 4
o
C with a mouse anti-acetylated α-tubulin primary 255 
antibody (1 : 100 dilution with PBS Santa Cruz Biotechnology, Santa Cruz, CA). The next 256 
morning the cells were washed three times in PBS (5 minutes per wash) and incubated 257 
with an Alexa 488 conjugated goat anti-mouse antibody (1:100 dilution with PBS, 258 
Santa Cruz Biotechnology, Santa Cruz, CA) at room temperature for 1 hour. Hoechst 259 
33342 (5 µg/mL) was used to stain cell nuclei and phalloidin conjugated to Alexa 568 260 
(1:100 dilution with PBS) was used to stain actin filaments. Negative controls were 261 
performed by omitting incubation with the primary antibody. Analysis was performed 262 
by laser scanning confocal microscopy using a TCS SPE-II system (Leica Microsystems 263 
GmbH, Wetzlar, Germany) attached to an inverted semi-automated DMI4000 264 
microscope (Leica) with a 40 x NA 1.25 magnification objective. Five random field of 265 
views in the center of the membrane and coverslip were imaged for each animal and 266 
group and, at least, 350 cells per animal and per group were classified; the percentage 267 
of ciliated cells was determined. Moreover, Z-stacks of 0.2 µm were obtained by laser 268 
scanning confocal microscopy at 100 x NA 1.40 magnification objective. 3D constructs 269 
of the cells were performed using ImageJ software (National Institutes of Health, 270 
Bethesda, MD, USA) to demonstrate cell morphology. 271 
Pieces of 5 mm from ampullary and isthmic regions of the oviduct ipsilateral to the 272 
ovary with an active corpus luteum were fixed for 24 hours in 4 % w/v 273 
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paraformaldehyde, paraffin embedded and sections of 4 µm were stained as described 274 
above. 275 
 276 
Live cell imaging 277 
After one week of the air-liquid interface culture, the oviduct-on-a-chip was incubated 278 
with MTR labeled sperm and stained with Hoechst 33342 (5 µg/mL) in the 3D culture 279 
medium for 30 minutes. Live cell imaging was done on a Nikon Eclipse TE2000 280 
equipped with the Perfect Focus System with a two-channel simultaneous imaging 281 
system by exciting with the lasers Vortran 405 nm and Cobolt Jive 561 nm, using the 282 
filters ET-DAPI (490/00) and ET-DSRed (490/05). Images from both channels were 283 
detected with a 20 x magnification long distance objective (Plan Apo 20x/NA 0.75 dry) 284 
with a speed of 60 frames per second.   285 
 286 
Detection of oocyte penetration 287 
Fixed presumptive zygotes were stained with Hoechst 33342 (5 µg/mL in PBS) for 30 288 
min, washed three times in PBS containing 3 mg/mL polyvinyl pyrrolidone (PVP) and 289 
then mounted into a 0.12 mm eight-well Secure-Seal Spacer (Molecular Probes) on a 290 
glass slide (Superfrost Plus; Menzel, Braunschweig, Germany), covered with 291 
Vectashield antifade (Vector Laboratories, Burlingame, CA), and sealed with a 292 
coverslip. Slides were analyzed by Laser scanning confocal microscopy using a TCS SPE-293 
II system (Leica Microsystems GmbH, Wetzlar, Germany) attached to an inverted semi-294 
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automated DMI4000 microscope (Leica) with a  40 x NA 1.25 magnification objective. 295 
The number of oocytes with the presence of labeled sperm mid-piece(s) within the 296 
ooplasm was determined (i.e. sperm-penetrated oocytes). Poly-spermy was identified 297 
by the detection of 2 or more sperm mid-pieces within the ooplasm, while parthenotes 298 
were identified in the case when 2 or more nuclei were detected without the presence 299 
of a sperm mid-piece. 300 
 301 
Data analysis  302 
The data were analyzed using IBM SPSS Statistics (version 24). A Shapiro-Wilk test was 303 
performed and all groups were normally distributed. Mean ± standard deviation is 304 
provided and differences between groups were examined by one-way ANOVA, 305 
followed by a Tukey’s post hoc analysis (p<0.05).  306 
 307 
Results and Discussion 308 
In this study, we designed and successfully 3D printed an oviduct-on-a-chip model 309 
using a stereo-lithographic technique (Figure 1). The chamber was designed such that 310 
its dimensions were compatible with live-cell imaging. Nowadays, 3D printing 311 
generates fast prototyping process technology, allowing researchers to design and 312 
print devices in a short period of time 
34
. On the other hand, research employing 313 
technologies, such as 3D printing and microfluidics, to bio-mimic 3D cultures for 314 
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reproductive events is scarce and only a handful of papers on 3D microfluidics and 315 
gamete research have been published 
36–40
.  316 
The oviductal lumen has a complex morphology due to folding of the mucosa of the 317 
oviduct wall. This folding varies in the different anatomical parts of the oviduct
41
. 318 
Exactly mimicking those folding in vitro is difficult and does not allow accurate live 319 
imaging. Therefore, we had to compromise our bio-mimicked model and decided to 320 
create an U-shape topology as this construct, at least, would allow live imaging and 321 
perfusion of the system, also providing a niche where more cell contact area is offered 322 
for introduced COCs. The oviduct-on-a-chip was designed in such a way that the 323 
distance between cells adhered to the porous filter and the glass coverslip was less 324 
than 2 mm, to meet the working distance of objectives available and permit live-cell 325 
imaging using an inverted epifluorescence microscope after incubation of the cells 326 
with MTR pre-labeled sperm (Supplementary movie 1). To our knowledge, this is the 327 
first published 3D printed device with a half-pipe shaped porous filter for BOEC 328 
culture. The potential benefits of this system for BOEC culture extend beyond the 329 
accessibility for live-cell imaging, since both the apical and basolateral compartments 330 
can be independently perfused or otherwise manipulated. The possibility of live 331 
imaging within the device is a significant advantage over currently available 332 
commercial porous membrane systems, and should allow a greater range of in vitro 333 
experiments, in particular those focusing on the changes within sperm cells during 334 
their incubation with oviduct epithelial cells just prior to fertilization and further 335 
embryonic development under different conditions.  336 
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When BOECs were cultured under 2D conditions the cells did not become ciliated but 337 
lost their columnar epithelium shape instead and became flat. This is in line with 338 
previous reports that describe this process known as de-differentiation 
25,27,42–44
. In 339 
contrast, BOECs cultured in the 3D printed device regained and maintained their 340 
ciliated and cuboidal to columnar pseudostratified epithelium for a period of at least 6 341 
weeks, with a mixed population of ciliated and non-ciliated secretory cells (Figure 2A 342 
to C). This morphology was comparable to the in vivo oviduct epithelium (Figure 2D 343 
and E). It was also possible to observe the formation of actin rich protrusions in non-344 
ciliated cells, the secretory bulbs. Cilia emerged at the air-liquid interface side of the 345 
cells (apical) within about 2 weeks of culture, was complete within 3 weeks and 346 
remained stable during weeks 3-6 of culture (P<0.05; Figure 3). Similar results have 347 
been described, previously, using porous membranes cultured at an air-liquid interface 348 
system for OECs derived from different species including mouse, cow, pig, monkey and 349 
man 
8,24,26–28,42,45
. However, such systems do not allow live-cell analysis and monitoring 350 
in contrast to the BOEC system described in our current study.  351 
The functionality of our oviduct-on-a-chip system was tested using a bio-monitoring 352 
assay in which sperm penetration of the oocyte was scored (this is indicative for 353 
fertilization). Although a lower percentage of oocytes was penetrated, compared to a 354 
standard bovine IVF system (Figure 4), the oviduct-on-a-chip system resulted in a 355 
similar proportion of oocytes that were mono-spermic fertilized (Figures 4 and 5). 356 
Remarkably, and in contrast to standard IVF, no parthenogenic oocyte activation nor 357 
poly-spermic fertilization was observed in our developed oviduct-on-a-chip fertilization 358 
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system (Figures 4 and 6). In contrast, parthenogenesis and poly-spermy both occurred 359 
with an incidence of approximately 10 % in the routine IVF system (Figure 4). Thus the 360 
developed oviduct-on-a-chip allowed similar normal fertilization of oocytes and 361 
completely reduced the incidence of abnormal fertilization/activation of oocytes when 362 
compared to routine IVF. Further to this, it should be noted that in our developed 363 
oviduct-on-a-chip system we have not added factors to the incubation media to 364 
stimulate sperm activation and capacitation in the model, in contrast to conventional 365 
bovine IVF where such additions are a routine requirement. Thus the apical fluid 366 
compartment must have been conditioned by the secretions of the polarized BOECs 367 
allowing similar mono-spermic fertilization rates to those achieved via conventional 368 
IVF.  369 
The reduced rates in poly-spermy and parthenogenic activation of oocytes in the 3D 370 
BOEC system was not due to a reduction of the amount sperm (non-bound sperm 371 
were perfused away) when compared to conventional IVF: the majority of sperm (86.3 372 
± 2.9 %) remained attached to the 3D BOEC (representing 69,000 ± 2,300 sperm per 373 
3D-BOEC). When a similar proportional reduction of sperm was used in conventional 374 
IVF (i.e. only 0.43 x 10
6 
instead of 0.5 x 10
6
 sperm per well) no differences on mono-375 
spermic penetration, poly-spermic penetration and parthenogenic activation was 376 
observed (for control 60.1%, 12.4% and 8.9%; for reduced number of sperm 55.63%, 377 
12.23% and 10.11%, respectively; p > 0.05). In another control we compared the 378 
fertilization results using 69,000 cells (the same number of sperm that remained 379 
bound in the 3D-BOEC) with 500,000 cells (normally used in conventional IVF).  The 380 
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large reduction of sperm resulted in severely reduced mono-spermic fertilization (20.5 381 
% versus 60.1 %; p <0.05) and a concomitant reduction of poly-spermic fertilization 382 
(5.1 % versus 12.5 %; p<0.05) while the parthenogenic activation rates remained the 383 
same (10.3% and 8.9%, p > 0.05). Note that both poly-spermic fertilization and 384 
parthenogenic activation of oocytes was not observed in the 3D-BOEC system: (i) The 385 
binding and activation of sperm to the 3D-BOEC and the absence of the activation 386 
factors are required to achieve high mono-spermic fertilization rates in combination 387 
with complete abolishment of poly-spermic fertilization and parthenogenic activation. 388 
(ii) In the 3D-BOEC system a strong reduction of number of sperm (13.8 %) leads to 389 
similar mono-spermic fertilization rates when compared to conventional IVF while 390 
such a reduction of sperm in conventional IVF leads to a severe reduction of mono-391 
spermic fertilization rates. (iii) Reducing the amount of sperm in conventional IVF, in 392 
presence of activation factors, does not reduce poly-spermic fertilization/mono-393 
spermic fertilization ratio (both are reduced to >60%) and does not reduce the 394 
incidence of parthenogenic activation.  Altogether these data confirm that the higher 395 
efficiency of mono-spermic fertilization (at low sperm dose) and the abolition of poly-396 
spermic fertilization as well as parthenogenic activation in the 3D BOEC culture IVF is 397 
due to an interaction between the sperm and/or the oocyte with the oviduct cells 398 
and/or secretions rather than to the severe reduction in number of sperm when 399 
compared to conventional IVF.   400 
Our results may indicate that routine IVF misses the optimal conditioning factors that 401 
are secreted by the oviduct epithelium and this absence caused the noted increase in 402 
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rates of oocytes that are abnormally parthenogenic activated or poly-spermic 403 
fertilized. Note that the activating factors used in conventional IVF are not responsible 404 
for the incidence of poly-spermic fertilization and/or parthenogenic activation of the 405 
oocytes (Figure 4). They only served to increase the mono-spermic fertililization rate to 406 
similar levels when compared to the 3D-BOEC, albeit approximately 7.2 times more 407 
sperm were needed in the conventional IVF when compared to the 3D-BOEC. This 408 
result further supports the notion that the oviduct-on-a-chip have conditioned and 409 
optimized the apical environment for mono-spermic fertilization. Altogether our data 410 
indicate that when OECs are cultured into a polarized and differentiated state within a 411 
3D topology, they appear to condition apical medium as they exclusively support 412 
mono-spermic fertilization. In the 2D culture system, where the majority of OECs were 413 
flat and non-ciliated, the conditioning of the apical medium was insufficient and did 414 
not inhibit poly-spermic fertilization (even though the total penetration rate was 415 
reduced).  416 
A reduction of poly-spermy  with even higher (74-84%) fertilization rates was 417 
demonstrated previously in an IVF system using BOECs cultured on porous membrane 418 
inserts 
8
. The major difference of that study and our approach is that we did not add 419 
any sperm activating components to the 3D BOEC culture medium. Moreover, in our 420 
oviduct-on-a-chip system we not only showed reduced rates but even a complete 421 
absence of both poly-spermic fertilization and parthenogenic activation. With regards 422 
to the higher fertilization rates in the former BOEC study
8
, the addition of estrous cow 423 
serum may have stimulated changes in the BOECs secretory activity. Studies to 424 
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examine the influence of factors such as endocrine stimulation, as well to investigate 425 
the influence of different segments of the oviduct (ampulla vs isthmus) on sperm 426 
activation and embryo development are planned for the oviduct-on-a-chip system. 427 
The concept that conditioning of the apical medium by the BOECs in the 3D system is 428 
responsible for preventing poly-spermy, is in line with previously described, inhibitory, 429 
effects of oviduct fluid on poly-spermic fertilization in cows and pigs 
46,47
. Moreover, 430 
studies have also reported beneficial effects of oviduct fluid and/or oviduct proteins on 431 
sperm motility, acrosome reaction, bull fertility 
3,8,48–54
 and on oocyte and embryo 432 
development and quality 
1,47,55–61
. Despite of this, the oviduct has remained a largely 433 
neglected organ when designing IVF procedures in man and domestic animals
17
. 434 
Note that epigenetic modulation of the maturing oocyte and the early developing 435 
embryo can also be of concern while producing embryos in vitro. In vivo these 436 
epigenetic events take place in the oviduct and are thought to allow reprogramming of 437 
the embryonic genome. For instance, the methylation of sperm DNA is erased in the 438 
paternal pronucleus after fertilization. Amongst other functions this process allows 439 
specific pluripotency genes to be expressed. Failure of, or disturbances to, this process 440 
leads to impaired embryo development 
62
. Interestingly, bovine blastocysts developed 441 
after culturing embryos partially in vitro and partially in vivo have been shown to differ 442 
in DNA methylation patterns when compared to blastocysts developed completely in 443 
vivo and to those completely developed in vitro 
13
.  444 
A classic example of the possible epigenetic effects of in vitro embryo production 445 
conditions on embryo development is the Large Offspring Syndrome (LOS), which is 446 
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characterized by increased size and weight at birth, breathing difficulties, reluctance to 447 
suckle, and perinatal death of the born calves 
63
. The LOS was described in cattle and 448 
sheep derived from in vitro cultured embryos in the presence of elevated serum 449 
concentrations
63
. The pathogenesis of the syndrome is not completely clear, but there 450 
is evidence that a loss of gene-imprinting and overexpression of insulin growth factor 2 451 
(IGF2) receptor may be an important contributor 
64,65
. The epigenetic changes that 452 
may be induced during embryo culture emphasize the need for improved in vitro 453 
embryo production systems. Not only the quantitative production of blastocysts, but 454 
also the quality and genetic normality of such embryos produced are highly relevant. 455 
We believe that the oviduct-on-a-chip approach will be an ideal starting point to better 456 
mimic the physiological environment for mammalian fertilization and embryo 457 
production. This more physiological environment likely serves to reduce metabolic and 458 
genetic programming abnormalities caused by in vitro embryo production conditions. 459 
Conclusions 460 
In conclusion, a 3D oviduct-on-a-chip model with a U-shaped porous membrane 461 
allowed BOEC polarization that could be maintained during long-term culture (over 6 462 
weeks). In this system the oviduct cells under culture must have conditioned the apical 463 
medium, as this allowed proper sperm and oocyte interactions, fertilization and 464 
completely abolished poly-spermic fertilization and parthenogenic activation of 465 
oocytes in the absence of added sperm activating factors. The oviduct-on-a-chip 466 
system is easy to manipulate, can be used for introduction, manipulation and live 467 
microscopic visualization of sperm cells, oocytes and early embryos and study their 468 
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cellular processes around fertilization. The fact that fertilization is exclusively mono-469 
spermic may become relevant for assisted reproductive technologies for both bovine 470 
and other mammalian species.  471 
 472 
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Figure legends 600 
 601 
Figure 1. Perspective visualization of the open device’s 3D printable model from 602 
above (A) and below (B). Schematic top (C), bottom (D), right (E) and front (F) view 603 
of the open device. Schematic right (G) and front (H) cross section of the closed 604 
device while being separately perfused with two (pink and blue) different types of 605 
media/cells. Dimensions are represented in millimeters. 606 
 607 
Figure 2. Confocal immune fluorescent images of bovine oviduct epithelial cells 608 
(BOECs) in 3D culture at an air-liquid interface for 28 days (A, B and C) and from 609 
paraffin sections of oviductal isthmus and ampulla (D and E, respectively). 610 
Acetylated α-tubulin was used to stain secondary cilia (green), phalloidin to label 611 
actin filaments (red in A, B and C) and Hoechst 33342 to stain nuclei (blue).  A, B and 612 
C: Note the presence of ciliated cells (green, white arrows), actin rich secretory 613 
protrusions (red, yellow arrows) and primary cilia (yellow arrow heads). In B, note 614 
the cuboid to columnar pseudostratified epithelium. D and E: Note columnar 615 
pseudostratified morphology of oviduct paraffin sections, similar to the one 616 
encountered in the 3D cultured BOEC. In paraffin embedded sections the phalloidin 617 
staining was not observed. The Z-stacks from top to bottom of the cells cultured on 618 
the 3D system can also be observed in the supplementary movie 2.   Bars = 25 µm. 619 
 620 
Figure 3. Average percentage of ciliated BOECs in 3D culture during weeks 3, 4, 5 621 
and 6 of air-liquid interface culture (n=4 animals). No difference was observed in 622 
the percentages of ciliated cells across the period studied (p>0.05). 623 
 624 
Figure 4. Mean percentage of COCs placed in maturation medium that were 625 
penetrated by sperm. In vitro fertilization was performed in four replicates using 626 
different systems: 3D culture (n=200 COCs), 2D culture (n=200 COCs) and in the 627 
absence of oviductal epithelial cells (with or without activation factors; n=300 COCs 628 
for each group). Total penetrated: different letters indicate values that differ 629 
statistically (p<0.05); Polyspermy: different numbers indicate values that differ 630 
statistically (p<0.05); Parthenogenesis: no differences were observed (p>0.05). 631 
Activation factors: heparin, penicillamine and hypothaurine. 632 
 633 
Figure 5. Monospermic oocyte penetration; Hoechst 33342 used to stain DNA (blue) 634 
and MTG used to label sperm mid pieces (green). Note the presence of maternal and 635 
paternal pronuclei (PN), the mid piece (white arrow) of the spermatozoa that 636 
penetrated the zona pellucida (ZP) and fertilized the oocyte, and spermatozoa 637 
attached to the zona pellucida (blue arrows). Bar = 50 µm.  638 
 639 
Figure 6. Confocal Z-stacks of a polyspermic penetrated oocyte, stained with Hoechst 640 
33342 for DNA (blue) and MTG for sperm mid piece (green). Note the presence of 641 
multiple pronuclei (PN), the mid piece (white arrows) of two sperm cells that 642 
penetrated the zona pellucida (ZP) and fertilized the oocyte; a sperm cell that 643 
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penetrated the ZP, but not the oolema (yellow arrow), and spermatozoa attached to 644 
the zona pellucida (blue arrows). Bar = 75 µm.  645 
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Figure 4 
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Figure 5 
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Figure 6 
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Video of live imaging 
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